Israeli Troops Detaining Growing Number of Civilians in Southwest Syria

Iran escalation, fragile debt markets, and gold flashing warning signs. Mark Thornton explains why this bubble won’t end gently.

Novo Nordisk Extends Slide After Announcing Price-Cuts For Blockbuster Obesity Drugs Novo Nordisk shares in Copenhagen can't catch a bid. The liquidation is accelerating again after a Bloomberg headline on Tuesday morning: the Danish drugmaker will slash U.S. list prices for Wegovy and Ozempic next year. The move suggests that the new CEO is pursuing market share amid intensifying competition in the GLP-1 space. Jamey Millar, Novo's head of U.S. operations, was quoted by Bloomberg as saying the company set a monthly price of $675 for its family of semaglutide drugs,...

Iran Will Be "Finding Out" Over Next 10 Days, Trump Says, But Asserts "Good Talks" Update(1021ET): As has become typical, President Trump is all over the place - his intentions ever more difficult to interpret - at a moment the media has highlighted Iraq war levels of military build-up in the Middle East with an eye on potential attack on Iran. On Thursday he oversaw the inaugural meeting in Washington DC of the Board of Peace related to Gaza. In televised remarks he surprisingly called tense negotiations with Iran "good talks". But then he...